At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Botulinum Toxin Type A +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intraoperative Injection of Botulinum Toxin A (Botox) for the Prevention of Post-Traumatic Elbow Stiffness: A Randomized Double Blind Placebo Controlled Study
In Brief
A clinical study evaluating Botulinum Toxin Type A and Saline for Post Traumatic Stiffness. Completed, enrolled 18 participants across 1 site.
Detailed Summary
This is a randomized double blind placebo controlled study to investigate the hypothesis that injection of botulinum toxin A into the muscles surrounding the elbow following the surgical treatment of an elbow fracture will reduce postoperative stiffness and improve function.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Traumatic Stiffness
CountriesUnited States
CollaboratorsAllergan
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2003
Primary CompletionSep 2009
Study CompletionMay 2010
First PostedMay 2010
TodayJul 2026
First PostedMay 24, 2010
Enrollment StartNov 1, 2003
Primary CompletionSep 1, 2009
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 16.1 years ago
Interventions
Botulinum Toxin Type Adrug
Injection into the biceps brachii and brachialis immediately following the initial fracture surgery
Salinedrug
Injection into the biceps brachii and brachialis immediately following the initial fracture surgery